Home › Funds › Tamar Securities, LLC › REGN

Tamar Securities, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

Tamar Securities, LLC reported holding 35,753 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$27.1M, representing 2.42% of its reported portfolio and ranking #16 among its reported holdings. Tamar Securities, LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)35.75K sh
Reported value held$27.11M
Portfolio Weight2.42%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Tamar Securities, LLC's REGN position evolved

Tamar Securities, LLC first disclosed a stake in REGN in Q3 2023 at 12,874 shares (US$10.6M). The position peaked in Q4 2025 at 40,456 shares, worth US$31.2M. Across 13 filings, Tamar Securities, LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 35,753 shares valued at US$27.1M — a reduction of -1,349 shares quarter over quarter.. Notable position changes include a 38% increase in Q1 2025 (shares fell 17% over the following quarter), a 100% trim in Q1 2026 (shares fell 18% over the following quarter), a 37002% increase in Q2 2026 (shares rose 22% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.87K $10.59M New
Q4 2023 14.23K $12.50M Add
Q1 2024 14.01K $13.49M Reduce
Q2 2024 13.28K $13.96M Reduce
Q3 2024 15.49K $16.29M Add
Q4 2024 20.40K $14.53M Add
Q1 2025 28.13K $17.84M Add
Q2 2025 30.38K $15.95M Add
Q3 2025 32.27K $18.14M Add
Q4 2025 40.46K $31.23M Add
Q1 2026 100 $77.26K Reduce
Q2 2026 37.10K $23.13M Add
Q3 2026 35.75K $27.11M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has Tamar Securities, LLC held REGN?

Tamar Securities, LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Tamar Securities, LLC's current position in REGN?

As of Q3 2026, Tamar Securities, LLC holds 35.75K shares of REGN (REGENERON PHARMACEUTICALS), valued at $27.11M, representing 2.42% of its reported portfolio and ranking #16.

Has Tamar Securities, LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), Tamar Securities, LLC reduced its position in REGN. The position peaked in Q4 2025 at 40.46K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.